Description

Arteemax 50 contains Artesunate 50mg, a semi-synthetic derivative of artemisinin. Artesunate is widely used as a first-line antimalarial agent due to its rapid action against malaria parasites, especially drug-resistant strains.

It is commonly prescribed as part of artemisinin-based combination therapy (ACT) to enhance treatment effectiveness and reduce the risk of resistance. Arteemax 50 plays a critical role in both uncomplicated and severe malaria management under medical supervision.

Usage Instructions

Take Arteemax 50 strictly as prescribed by a healthcare professional

Dosage and duration depend on malaria severity and patient factors

Swallow the tablet with water

Often used in combination with other antimalarial medicines

Complete the full treatment course even if symptoms improve

⚠️ Never self-medicate for malaria without proper diagnosis.

Medicinal Advantages

Rapid reduction of malaria parasite load

Effective against drug-resistant Plasmodium falciparum

Well-tolerated when used as directed

Reduces complications and disease progression

Supported by WHO malaria treatment guidelines

Clinical evidence supports artesunate as a cornerstone therapy in malaria control.

Possible Side Effects

Some patients may experience:

Nausea or vomiting

Dizziness

Headache

Mild gastrointestinal discomfort

Serious side effects are rare. Seek medical attention immediately if allergic reactions or unusual symptoms occur.